NIH Funding · FY2024
Total Funding
$2.9M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#2,722
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $2.9M across 3 grants · National rank #2722.
Top grants by award amount
Christian Furlan Freguia's NIH grant portfolio, ranked by award amount.
- 5R44DK137649-02R44R-5280, A Novel Modified Superior Resistant Starch Therapy for Type 1 Diabetes$995.9Kaward amount
- 5R44AI174332-02R44A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)$984.4Kaward amount
- 4R44AI174844-02R44A Novel Immunological-Directed Synthetic Biology-Based Drug for the Treatment of Multiple Sclerosis$956Kaward amount
Affiliation
Institutions that have administered grants for Christian Furlan Freguia.
Affiliated with Rise Therapeutics, LLC (MD).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH AwardRise Therapeutics, LLC
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #2722
- 2024Entered Top 25% NationallyRanked #2722
Related investigators
Other NIH-funded PIs frequently associated with Christian Furlan Freguia.
Explore further
Find collaborators for Christian Furlan Freguia
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at Rise Therapeutics, LLC
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →